🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Which Patient Group Shows Greater Improvement With Patient Education Alone in Rotator Cuff-Related Shoulder Pain? - A Cohort Study

RecruitingNAAges 18 Years - 65 YearsAllIstanbul University - Cerrahpasa
NCT07324343 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The primary aim of this study is to determine the clinical effectiveness of patient education alone in individuals with rotator cuff-related shoulder pain and to identify which patient subgroups benefit more from this approach. In addition, the translation and cultural adaptation of the "Patient Knowledge Questionnaire (PKQ-RCRSP)" into Turkish will be carried out to measure the level of patient knowledge regarding patient education.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Individuals aged 18-65 years * Shoulder pain persisting for at least 4 weeks * Diagnosed by an orthopedic physician with impingement, subacromial bursitis, rotator cuff (RC) tendinopathy, or partial tear * Activity-related pain ≥3 on the NPRS * Cognitively able to understand the education and provide written informed consent Exclusion Criteria: * History of shoulder surgery * Diagnosis of frozen shoulder, full-thickness or massive rotator cuff (RC) tear, or instability * Presence of neurological or psychiatric conditions that prevent exercise * History of physical therapy-rehabilitation or injection treatment within the past 6 months * Pain persisting for more than 12 months
💊

What it tests

  • Questionnaire Validation
  • Patient Education
📍

Where

1 site
İstanbul University Cerrahpasa Faculty of Health Sciences, İstanbul
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy